NEW YORK (GenomeWeb News) - Galapagos and Cellzome today said that they are collaborating in kinase drug discovery.
Under the terms of the agreement, Galapagos' service division BioFocus DPI will provide its SoftFocus kinase libraries to Cellzome. BioFocus will also provide biological screening and chemistry expertise to find inhibitors of Cellzome's kinase targets, the companies said.
The companies will use Cellzome's proprietary proteomics technology, Kinobeads, to screen the BioFocus DPI libraries in order to identify inhibitors against inflammatory kinases.
As part of the service contract, BioFocus DPI will receive an upfront payment for the library access as well as research fees. Further financial details were not disclosed.